IL1RL1 and arthritic joint disease: Studies in animal models demonstrated that recombinant IL1RL1 isoform B protein, or anti-IL1RL1 antibody could significantly attenuate the severity of experimental arthritis [60, 61] and IL1RL1 knock-out mice were shown to develop less severe form of disease and had reduced pro-inflammatory cytokine production.